𝔖 Bobbio Scriptorium
✦   LIBER   ✦

One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial

✍ Scribed by Stefanie Schulz; K. Anette Birkmeier; Gjin Ndrepepa; Werner Moshage; Franz Dotzer; Kurt Huber; Josef Dirschinger; Melchior Seyfarth; Albert Schömig; Adnan Kastrati; Julinda Mehilli

Publisher
Springer
Year
2010
Tongue
English
Weight
301 KB
Volume
99
Category
Article
ISSN
1861-0684

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feature topic: Clinical use of abciximab
Feature topic: Clinical use of abciximab: Coronary artery stenting for suboptimal PTCA results in acute myocardial infarction in patients treated with abciximab: Early and six-month outcome
✍ Murdock, David K. ;Logemann, Timothy ;Hoffmann, Mark T. ;Olson, Karen J. ;Engelm 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

Emergent percutaneous transluminal coronary angioplasty (PTCA) is an effective treatment for acute myocardial infarction. However, occasionally results of angioplasty are suboptimal due to coronary dissection or elastic recoil, leading to a high chance of recurrent ischemia. Coronary stents are occa